Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas, Adenocarcinoma”

2,144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,144 results

Testing effectiveness (Phase 2)Looking for participantsNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Early research (Phase 1)Ended earlyNCT04807972
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Who this might be right for
Pancreatic Cancer
AbbVie 40
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Not applicableStudy completedNCT05884463
What this trial is testing

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Who this might be right for
18F-FAPI18F-FDGPancreas Adenocarcinoma+2 more
Zhejiang University 62
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT06344299
What this trial is testing

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 5,302
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Large-scale testing (Phase 3)Looking for participantsNCT07076121
What this trial is testing

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb 470
Early research (Phase 1)Study completedNCT05383352
What this trial is testing

Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Ipsen 177
Not applicableStudy completedNCT02072616
What this trial is testing

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Who this might be right for
Circulating Tumor CellsPancreatic AdenocarcinomaCirculating Tumor DNA (KRAS)+1 more
University Hospital, Rouen 101
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Not applicableStudy completedNCT01765036
What this trial is testing

Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Société Française d'Endoscopie Digestive 100
Testing effectiveness (Phase 2)Study completedNCT02243371
What this trial is testing

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Who this might be right for
Previously Treated Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 93
Early research (Phase 1)UnknownNCT03703063
What this trial is testing

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 30
Not applicableLooking for participantsNCT04037007
What this trial is testing

Efficacy of Fistulotomy for Biliary Cannulation

Who this might be right for
CholangiocarcinomaCholedocholithiasis; CholangitisPancreatic Cancer+1 more
Coordinación de Investigación en Salud, Mexico 320
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Not applicableUnknownNCT02079363
What this trial is testing

DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer

Who this might be right for
Pancreatic DiseasesPancreatic NeoplasmsPancreatitis
Aalborg University Hospital 330
Not applicableUnknownNCT03865875
What this trial is testing

Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Not applicableEnded earlyNCT01071434
What this trial is testing

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Who this might be right for
Pancreatic CancerLiver CancerLung Cancer+7 more
Stanford University 5
Load More Results